US Approval Denied, PTV News: May 05, 2010




Episode Loading...




PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: US Approval Denied, PTV News: May 05, 2010
Released on: May 05, 2010. © PharmaVentures Ltd
Visitors: You are watching a 1 minute preview.
Share/save this page:
Email
Bookmark
Facebook
Twitter
LinkedIn
Follow us:
RSS
Twitter
  • Summary
  • Transcript
  • Company
FDA decides against approving Dainippon's anti-epileptic Stedesa
Full video transcripts are available with PharmaTelevision Premium Content. Click here to buy a subscription or sign up for a 14 day free trial.
Dainippon Sumitomo Pharma
Dainippon Sumitomo Pharma is a pharmaceutical corporation committed to serving the social good through research and development programs, designed to allow people to lead fuller, healthier lives.
Food and Drug Administration (FDA)
The Food and Drug Administration (FDA or USFDA) is an agency of the United States Department of Health and Human Services, one of the United States federal executive departments, responsible for protecting and promoting public health through the regulation and supervision of food safety, tobacco products, dietary supplements, prescription and over-the-counter pharmaceutical drugs (medications), vaccines, biopharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices (ERED), veterinary products, and cosmetics.
Sepracor
Sepracor Inc. is a fully integrated, research-based specialty pharmaceutical company dedicated to treating and preventing human disease by discovering, developing and commercialising innovative pharmaceutical products that are directed toward serving large and growing markets and unmet medical needs.